...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Validation of Available Extended-Spectrum-Beta-Lactamase Clinical Scoring Models in Predicting Drug Resistance in Patients with Enteric Gram-Negative Bacteremia Treated at South Texas Veterans Health Care System
【24h】

Validation of Available Extended-Spectrum-Beta-Lactamase Clinical Scoring Models in Predicting Drug Resistance in Patients with Enteric Gram-Negative Bacteremia Treated at South Texas Veterans Health Care System

机译:验证南德克萨斯退伍军人卫生保健系统治疗肠革兰阴性菌血症患者患者患者耐药性的可用扩展光谱 - β-内酰胺酶临床评分模型

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Extended-spectrum-beta-lactamase (ESBL)-producing Enterobacteriaceae are increasingly common; however, predicting which patients are likely to be infected with an ESBL pathogen is challenging, leading to increased use of carbapenems. To date, five prediction models have been developed to distinguish between patients infected with ESBL pathogens. The aim of this study was to validate and compare each of these models to better inform antimicrobial stewardship. This was a retrospective cohort study of patients with Gram-negative bacteremia treated at the South Texas Veterans Health Care System over 3 months from 2018 to 2019. We evaluated isolate, clinical syndrome, and score variables for the five published prediction models/scores: Italian "Tumbarello," Duke, University of South Carolina (USC), Hopkins clinical decision tree, and modified Hopkins. Each model was assessed using the area under the receiver operating characteristic curve (AUROC) and Pearson correlation. One hundred forty-five patients were included for analysis, of which 20 (13.8%) were infected with an ESBL Escherichia coli or Klebsiella spp. The most common sources of infection were genitourinary (55.8%) and gastrointestinal/intraabdominal (24.1%), and the most common pathogen was E. coli (75.2%). The prediction model with the strongest discriminatory ability (AUROC) was Tumbarello (0.7556). The correlation between prediction model score and percent ESBL was strongest with the modified Hopkins model (R-2 = 0.74). In this veteran population, the modified Hopkins and Duke prediction models were most accurate in discriminating between Gram-negative bacteremia patients when considering both AUROC and correlation. However, given the moderate discriminatory ability, many patients with ESBL Enterobacteriaceae (at least 25%) may still be missed empirically.
机译:产超广谱β-内酰胺酶(ESBL)的肠杆菌科细菌越来越常见;然而,预测哪些患者可能感染ESBL病原体具有挑战性,这导致碳青霉烯类药物的使用增加。迄今为止,已经开发了五种预测模型来区分感染ESBL病原体的患者。这项研究的目的是验证和比较每一种模型,以便更好地为抗菌药物管理提供信息。这是一项回顾性队列研究,研究对象是2018年至2019年间在南得克萨斯州退伍军人医疗系统接受3个月治疗的革兰氏阴性菌血症患者。我们评估了五个已发表的预测模型/分数的分离、临床症候群和得分变量:意大利语“TunbaRLLO”、杜克、南卡罗来纳州大学(USC)、霍普金斯临床决策树和改良霍普金斯。利用受试者工作特征曲线下面积(AUROC)和皮尔逊相关系数对每个模型进行评估。纳入145例患者进行分析,其中20例(13.8%)感染了ESBL大肠杆菌或克雷伯菌属。最常见的感染源是泌尿生殖道(55.8%)和胃肠道/腹腔内(24.1%),最常见的病原体是大肠杆菌(75.2%)。判别能力最强的预测模型(AUROC)为Tumbarello(0.7556)。预测模型得分与ESBL百分比之间的相关性在改良霍普金斯模型中最强(R-2=0.74)。在这个退伍军人群体中,当考虑AUROC和相关性时,改良的霍普金斯和杜克预测模型在区分革兰氏阴性菌血症患者方面最为准确。然而,鉴于ESBL肠杆菌科的中度鉴别能力,许多ESBL肠杆菌科患者(至少25%)仍可能被经验遗漏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号